A lung cancer researcher from Dartmouth College has received a $1.5 million grant from the National Cancer Institute to build and validate machine leaning approaches to develop better, more personalized cancer treatments.

The combination of machine learning and ultrasound could help healthcare providers with the diagnosis of thyroid nodules, according to new findings published in JAMA Otolaryngology.

Partners HealthCare has launched two new investment funds designed to improve funding for AI solutions and other key technologies.

Researchers have trained a machine learning model to identify patients with familial hypercholesterolemia (FH), a genetic disorder that increases a person’s risk of coronary artery disease.

Deep learning can be used to predict the future hospitalization of pediatric patients, according to new research published in the American Journal of Managed Care

AI technologies are making a significant impact on the health of patients throughout Asia, according to a new report from MIT Technology Review Insights.

Merck KGaA, a Darmstadt, Germany-based pharmaceutical company, is hoping AI can improve its ability to predict drug shortages and plan accordingly.

Researchers have developed a new blood test that could lead to improved brain cancer diagnoses, according to new findings published in Nature Communications.

Machine learning models can tell us a lot about how patients sleep, according to new research published in PLOS One. And it’s much less obtrusive than prior methods.

The British Heart Foundation (BHF) has awarded researchers at University College London (UCL) £1 million ($1.27 million) to study cardiovascular disease. The funding will be used to bring in a new team of researchers and develop a research center focused on AI.

A team of researchers from West Virginia and Arkansas are beginning a four-year project aimed at using AI to improve the treatment of cardiovascular disease and cut healthcare costs.

Insilico Medicine, a Hong Kong-based AI company, has announced a new collaboration with Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. (CTFH) aimed at improving care for breast cancer patients.